Pages that link to "Q73425262"

The following pages link to High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes (Q73425262):

Displaying 14 items.

• Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses (Q33762518) (← links)
• Separation methods for alkylating antineoplastic compounds. (Q34510200) (← links)
• Acrolein detection: potential theranostic utility in multiple sclerosis and spinal cord injury (Q34888636) (← links)
• Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention (Q35788081) (← links)
• A Reduction-Based Sensor for Acrolein Conjugates with the Inexpensive Nitrobenzene as an Alternative to Monoclonal Antibody (Q37367018) (← links)
• Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes. (Q38326139) (← links)
• Role of metabolites of cyclophosphamide in cardiotoxicity. (Q41414219) (← links)
• Determination of acrolein in human urine by headspace gas chromatography and mass spectrometry. (Q42537311) (← links)
• Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. (Q42802201) (← links)
• Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry (Q44472513) (← links)
• Quantitative high-performance liquid chromatographic determination of acrolein in plasma after derivatization with Luminarin® 3 (Q56484967) (← links)
• Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide (Q58483640) (← links)
• Lipoxidation in cardiovascular diseases. (Q64953092) (← links)
• Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography-mass spectrometry (Q78014689) (← links)